Xvivo Perfusion AB (publ) XVIVO.ST Stock
Xvivo Perfusion AB (publ) Price Chart
Xvivo Perfusion AB (publ) XVIVO.ST Financial and Trading Overview
Xvivo Perfusion AB (publ) stock price | 323.5 SEK |
Previous Close | 293.5 SEK |
Open | 293.5 SEK |
Bid | 292 SEK x 0 |
Ask | 293.5 SEK x 0 |
Day's Range | 290.5 - 295.5 SEK |
52 Week Range | 127.8 - 310 SEK |
Volume | 1.22K SEK |
Avg. Volume | 23.78K SEK |
Market Cap | 8.76B SEK |
Beta (5Y Monthly) | 2.017241 |
PE Ratio (TTM) | 298.97958 |
EPS (TTM) | 3.07 SEK |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 396.67 SEK |
XVIVO.ST Valuation Measures
Enterprise Value | 8.65B SEK |
Trailing P/E | 298.97958 |
Forward P/E | 65.69507 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 18.910948 |
Price/Book (mrq) | 6.0411124 |
Enterprise Value/Revenue | 18.674 |
Enterprise Value/EBITDA | 287.856 |
Trading Information
Xvivo Perfusion AB (publ) Stock Price History
Beta (5Y Monthly) | 2.017241 |
52-Week Change | 32.20% |
S&P500 52-Week Change | 20.43% |
52 Week High | 310 SEK |
52 Week Low | 127.8 SEK |
50-Day Moving Average | 278.92 SEK |
200-Day Moving Average | 216.97 SEK |
XVIVO.ST Share Statistics
Avg. Volume (3 month) | 23.78K SEK |
Avg. Daily Volume (10-Days) | 23.73K SEK |
Shares Outstanding | 29.9M |
Float | 23.61M |
Short Ratio | N/A |
% Held by Insiders | 12.25% |
% Held by Institutions | 55.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.00% |
Operating Margin (ttm) | 4.19% |
Gross Margin | 72.65% |
EBITDA Margin | 6.48% |
Management Effectiveness
Return on Assets (ttm) | 0.74% |
Return on Equity (ttm) | 2.02% |
Income Statement
Revenue (ttm) | 463.25M SEK |
Revenue Per Share (ttm) | 15.65 SEK |
Quarterly Revenue Growth (yoy) | 51.80% |
Gross Profit (ttm) | 296.96M SEK |
EBITDA | 30.05M SEK |
Net Income Avi to Common (ttm) | 27.84M SEK |
Diluted EPS (ttm) | 0.98 |
Quarterly Earnings Growth (yoy) | 197.50% |
Balance Sheet
Total Cash (mrq) | 197.95M SEK |
Total Cash Per Share (mrq) | 6.64 SEK |
Total Debt (mrq) | 18.65M SEK |
Total Debt/Equity (mrq) | 1.29 SEK |
Current Ratio (mrq) | 3.307 |
Book Value Per Share (mrq) | 48.501 |
Cash Flow Statement
Operating Cash Flow (ttm) | 24.78M SEK |
Levered Free Cash Flow (ttm) | -95715872 SEK |
Profile of Xvivo Perfusion AB (publ)
Country | Sweden |
State | N/A |
City | Gothenburg |
Address | MAessans gata 10 |
ZIP | 412 51 |
Phone | 46 3 17 88 21 50 |
Website | https://www.xvivoperfusion.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 137 |
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Q&A For Xvivo Perfusion AB (publ) Stock
What is a current XVIVO.ST stock price?
Xvivo Perfusion AB (publ) XVIVO.ST stock price today per share is 323.5 SEK.
How to purchase Xvivo Perfusion AB (publ) stock?
You can buy XVIVO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xvivo Perfusion AB (publ)?
The stock symbol or ticker of Xvivo Perfusion AB (publ) is XVIVO.ST.
Which industry does the Xvivo Perfusion AB (publ) company belong to?
The Xvivo Perfusion AB (publ) industry is Medical Devices.
How many shares does Xvivo Perfusion AB (publ) have in circulation?
The max supply of Xvivo Perfusion AB (publ) shares is 31.5M.
What is Xvivo Perfusion AB (publ) Price to Earnings Ratio (PE Ratio)?
Xvivo Perfusion AB (publ) PE Ratio is 105.37459600 now.
What was Xvivo Perfusion AB (publ) earnings per share over the trailing 12 months (TTM)?
Xvivo Perfusion AB (publ) EPS is 3.07 SEK over the trailing 12 months.
Which sector does the Xvivo Perfusion AB (publ) company belong to?
The Xvivo Perfusion AB (publ) sector is Healthcare.
Xvivo Perfusion AB (publ) XVIVO.ST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
OMX_Nordic_Mid_Cap_ISK_GI OMXNMCISKGI | 622.38 ISK 4.58 USD |
-0.43
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 439.38 DKK 64.42 USD |
-0.4
|
— — | — — | — — | — - | — — |
NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
OMX Stockholm Medical Equipment SX201020GI | 1855.58 SEK 181.13 USD |
-1.1
|
— — | — — | — — | — - | — — |
OMX_Stockholm_Mid_Cap_PI OMXSMCPI | 1516.78 SEK 148.06 USD |
-0.02
|
— — | — — | — — | — - | — — |
OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 548.69 SEK 53.56 USD |
+0.07
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 439.19 EUR 480.1 USD |
-0.42
|
— — | — — | — — | — - | — — |
OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care Equip SX4530GI | 1816.79 SEK 177.34 USD |
<0.01
|
— — | — — | — — | — - | — — |
NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
OMX Stockholm Medical Equipment SX201020PI | 1557.67 SEK 152.05 USD |
-1.1
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}